Picture of AbCellera Biologics logo

ABCL — AbCellera Biologics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: Abcellera Reports Full Year 2022 Business Results

Feb 21 (Reuters) - Abcellera Biologics Inc  ABCL.O :
    * ABCELLERA REPORTS FULL YEAR 2022 BUSINESS RESULTS
    * NET LOSS FOR Q4 WAS $29.9 MILLION, OR $0.10 PER SHARE ON A
BASIC
AND DILUTED BASIS
    * REVENUE FOR Q4 OF 2022 WAS $21.5 MILLION, REPRESENTING 4%
OF
TOTAL FOR 2022
    * OPERATING EXPENSES TOTALED $59.3 MILLION IN Q4
    * Q4 EARNINGS PER SHARE VIEW $-0.01, REVENUE VIEW $50.8
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nBw5SSzzpa 
Further company coverage:  ABCL.O 
 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on AbCellera Biologics

See all news